Neuberger Berman Group
VBIV

Neuberger Berman Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Neuberger Berman Group’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-417
Closed -$26K – 1641
2016
Q2 		$26K Buy
+417
New +$41.8K ﹤0.01% 1530

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Neuberger Berman Group's VBIV Position: Q3 2016 in Review

Neuberger Berman Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2016, closing a stake of 417 shares — an estimated $26K sold.

Neuberger Berman Group first reported a position in VBIV in Q2 2016 and held it in 1 quarter. The position peaked at $26K in Q2 2016. 20 funds tracked by Wall St. Rank hold VBIV as of Q3 2016.

  • Neuberger Berman Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2016 after selling out during the quarter.
  • Neuberger Berman Group sold 417 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2016, an estimated $26K.
  • Neuberger Berman Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2016 and held it in 1 quarter.
  • Neuberger Berman Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $26K in Q2 2016.
  • 20 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2016.

Based on Neuberger Berman Group's 13F filing for Q3 2016, filed 2 Nov 2016.